Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial
JAMA (2021) - Comments
doi: 10.1001/jama.2020.25864  issn: 0098-7484  pubmed: 33464336  issn: 1538-3598 

Renato D. Lopes, Ariane V. S. Macedo, Pedro G. M. De Barros E Silva, Renata J. Moll-Bernardes, Tiago M. Dos Santos, Lilian Mazza, André Feldman, Guilherme D’Andréa Saba Arruda, Denílson C. De Albuquerque, Angelina S. Camiletti, Andréa S. De Sousa, Thiago C. De Paula, Karla G. D. Giusti, Rafael A. M. Domiciano, Márcia M. Noya-Rabelo, Alan M. Hamilton, Vitor A. Loures, Rodrigo M. Dionísio, Thyago A. B. Furquim, Fábio A. De Luca